Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. For the third quarter, Astrana projected revenue of $1 billion to $1.03 billion and adjusted EBITDA of $72.5 million to $77.5 million. Value-Based Care Expansion and Cost TrendsAt the end of the quarter, Astrana had about 1.5 million members in value-based arrangements. About Astrana Health (NASDAQ:ASTH)Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement.